Market Cap : 226.78 B | Enterprise Value : 245.7 B | PE Ratio : 13.69 | PB Ratio : 5.23 |
---|
NYSE:MRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Merck's quick ratio for the quarter that ended in Jun. 2022 was 1.15.
Merck has a quick ratio of 1.15. It generally indicates good short-term financial strength.
The historical rank and industry rank for Merck's Quick Ratio or its related term are showing as below:
During the past 13 years, Merck's highest Quick Ratio was 3.44. The lowest was 0.69. And the median was 1.15.
MRK's Quick Ratio is ranked worse thanThe historical data trend for Merck's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Merck's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Merck's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Merck's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Merck's Quick Ratio for the fiscal year that ended in Dec. 2021 is calculated as
Quick Ratio (A: Dec. 2021 ) | = | (Total Current Assets | - | Total Inventories) | / | Total Current Liabilities |
= | (30266 | - | 5953) | / | 23872 | |
= | 1.02 |
Merck's Quick Ratio for the quarter that ended in Jun. 2022 is calculated as
Quick Ratio (Q: Jun. 2022 ) | = | (Total Current Assets | - | Total Inventories) | / | Total Current Liabilities |
= | (32116 | - | 5535) | / | 23168 | |
= | 1.15 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Thank you for viewing the detailed overview of Merck's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Douglas M Jr | director | 370 WBASHA ST NORTH ST PAUL MN 55102 |
Oosthuizen Johannes Jacobus | officer: SVP, U.S. Market | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Garay Arpa | officer: SVP Human Health Global Mktg. | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Downing Cristal N | officer: Chief Comm. & Public Afrs Ofcr | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Klobuchar Michael A | officer: EVP - Chief Strategy Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Lecointe-cephas Lisa | officer: SVP Chief Ethics & Com Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Litchfield Caroline | officer: EVP & CFO | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Mayo Stephen | director | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Li Dean Y | officer: Executive VP & President, MRL | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Williams David Michael | officer: EVP,Chief Info&Digital Officer | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Lavizzo-mourey Risa J | director | GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210 |
Seidman Christine E | director | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Warden Kathy J | director | 2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042 |
Craig Pamela | director | C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601 |
Brun Leslie A | director | 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 |
From GuruFocus
Other Sources
By Zacks 2022-03-29
By Zacks 2022-03-31
By Zacks 2022-03-22
By tipranks.com 2022-03-28
By Zacks 2022-03-28
By Fool 2022-04-05
By Zacks 2022-04-04
By Zacks 2022-04-05
By Zacks 2022-03-22
By Zacks 2022-03-25
By Zacks 2022-04-05
By Zacks 2022-03-28
By Zacks 2022-03-28
By Zacks 2022-03-25
By tipranks.com 2022-04-05